UBS AM’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-80,394
| Closed | -$137K | – | 2854 |
|
|
2018
Q3 | $137K | Hold |
80,394
| – | – | ﹤0.01% | 2502 |
|
|
2018
Q2 | $140K | Hold |
80,394
| – | – | ﹤0.01% | 2534 |
|
|
2018
Q1 | $147K | Hold |
80,394
| – | – | ﹤0.01% | 2429 |
|
|
2017
Q4 | $179K | Hold |
80,394
| – | – | ﹤0.01% | 2340 |
|
|
2017
Q3 | $233K | Buy |
80,394
+1,615
| +2% | +$4.68K | ﹤0.01% | 2179 |
|
|
2017
Q2 | $351K | Buy |
78,779
+143
| +0.2% | +$636 | ﹤0.01% | 1975 |
|
|
2017
Q1 | $366K | Buy |
78,636
+25,300
| +47% | +$118K | ﹤0.01% | 1949 |
|
|
2016
Q4 | $325K | Sell |
53,336
-5,500
| -9% | -$33.5K | ﹤0.01% | 1918 |
|
|
2016
Q3 | $325K | Buy |
58,836
+14,436
| +33% | +$79.7K | ﹤0.01% | 2224 |
|
|
2016
Q2 | $169K | Hold |
44,400
| – | – | ﹤0.01% | 2494 |
|
|
2016
Q1 | $123K | Sell |
44,400
-5,300
| -11% | -$14.7K | ﹤0.01% | 2542 |
|
|
2015
Q4 | $282K | Sell |
49,700
-585,200
| -92% | -$3.32M | ﹤0.01% | 2369 |
|
|
2015
Q3 | $3.37M | Sell |
634,900
-3,800
| -0.6% | -$20.1K | ﹤0.01% | 1195 |
|
|
2015
Q2 | $5.3M | Buy |
638,700
+3,300
| +0.5% | +$27.4K | 0.01% | 1039 |
|
|
2015
Q1 | $2.94M | Buy |
635,400
+2,600
| +0.4% | +$12K | ﹤0.01% | 1213 |
|
|
2014
Q4 | $1.93M | Buy |
632,800
+13,000
| +2% | +$39.6K | ﹤0.01% | 1339 |
|
|
2014
Q3 | $1.73M | Hold |
619,800
| – | – | ﹤0.01% | 1356 |
|
|
2014
Q2 | $2.52M | Hold |
619,800
| – | – | ﹤0.01% | 1242 |
|
|
2014
Q1 | $3.29M | Sell |
619,800
-8,677
| -1% | -$46.1K | ﹤0.01% | 1151 |
|
|
2013
Q4 | $3.49M | Sell |
628,477
-4,969
| -0.8% | -$27.6K | ﹤0.01% | 1105 |
|
|
2013
Q3 | $2.86M | Buy |
+633,446
| New | +$2.86M | ﹤0.01% | 1128 |
|